id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0628-0010,FDA,FDA-2010-P-0628,FDA/CDER Response to Heyl Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Letter,Other,Letter(s),2011-08-24T04:00:00Z,2011,8,2011-08-24T04:00:00Z,,2012-05-09T22:55:06Z,,0,0,0900006480eeb82b
FDA-2010-P-0628-0009,FDA,FDA-2010-P-0628,"Determination That PENTETATE CALCIUM TRISODIUM (Trisodium Calcium Diethylenetriaminepentaacetate) Solution for Intravenous or Inhalation Administration, Equivalent to 1 Gram Base/5 Milliliters (Equivalent to 200 Milligrams Base/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,General Notice,2011-08-19T04:00:00Z,2011,8,,,2012-05-09T22:45:19Z,2011-21227,0,0,0900006480ee56e2
FDA-2010-P-0628-0004,FDA,FDA-2010-P-0628,"Attachment I - ""Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations"" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T19:14:05Z,,0,0,0900006480bb2c17
FDA-2010-P-0628-0006,FDA,FDA-2010-P-0628,"Attachment V - Breustedt, B. et al, ""Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements"" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T19:18:35Z,,0,0,0900006480bb30db
FDA-2010-P-0628-0007,FDA,FDA-2010-P-0628,"Attachment VII - ""Mayak Worker Study Project 2.4 Volume III Internal Dosimetry Dose Reconstruction Methods Used in Preparation of Doses-2005 Database"" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T19:19:56Z,,0,0,0900006480bb30de
FDA-2010-P-0628-0005,FDA,FDA-2010-P-0628,"Attachment II - ""Federal Register/ Vol. 68, No. 178/ Monday, September 15, 2003/Notice"" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T19:16:46Z,,0,0,0900006480bb2c18
FDA-2010-P-0628-0008,FDA,FDA-2010-P-0628,"Attachment XI - ""IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids"" Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-12-27T05:00:00Z,2010,12,,,2010-12-27T19:36:22Z,,0,0,0900006480bb30e2
FDA-2010-P-0628-0003,FDA,FDA-2010-P-0628,"Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Correction",Other,CR-Correction,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2013-07-27T23:40:14Z,,0,0,0900006480bbd27f
FDA-2010-P-0628-0001,FDA,FDA-2010-P-0628,"Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition",Other,CP-Citizen Petition,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-07-27T23:39:14Z,,0,0,0900006480bb2bb2
FDA-2010-P-0628-0002,FDA,FDA-2010-P-0628,"Acknowledgement Letter to Heyltex Corporation, Heyl Chemisch-Pharmazeutische Fabrik GnbH & Co. KG",Other,Acknowledgement Letter/Receipt,2010-12-20T05:00:00Z,2010,12,2010-12-20T05:00:00Z,,2013-08-11T04:43:15Z,,0,0,0900006480bb32df